VIRTUAL GLOBAL FORUM ON TB VACCINES

20-22 April 2021

Advancing TB vaccines in the time of COVID-19

The Global Forum on TB Vaccines brings together stakeholders from across the spectrum of TB vaccine research and development to share data, concepts, and new approaches to tuberculosis vaccine R&D, as well as promote a global dialogue on the path forward for this critical research.

Due to the ongoing coronavirus pandemic, a Virtual Global Forum on TB Vaccines will be convened from 20 - 22 April 2021. It will provide an overview of the state of the field and recent progress in TB vaccine R&D against the backdrop of the COVID-19 pandemic; and convene researchers, developers, funders and other stakeholders remotely to discuss opportunities and challenges for TB vaccine R&D in these unprecedented times.

Read our full statement on COVID-19

The 6th Global Forum on TB Vaccines will be convened in Toulouse, France from 22 - 24 February 2022.

6TH GLOBAL FORUM WEBSITE
virtual global forum platform Log in

If you did not receive the email with your credentials, click on the log in button above and then click on "Forgot my password." You will get an email from invite@allintheloop.com that will allow you to reset your password and log in. If you do not get this email, please check your spam or junk folders. If you still do not find it, please contact support@allintheloop.com.

The main goals of the Global Forum are to:

Progress

Review progress and share the latest research and data

Promote-vaccine

Identify and promote innovative and transformative approaches to TB vaccine R&D

Encourage-partnerships

Encourage partnerships and collaboration to accelerate TB vaccine R&D

Increase-recognition

Increase global recognition of the critical role vaccines will play in efforts to end TB

Sign up for information and updates about the Global Forum

Sign-Up For Updates

INTERNATIONAL CONVENING OF THE

ORGANIZED IN COLLABORATION WITH

SPONSORED BY

Funding for this conference was made possible [in part] by 1 R13 AI 157206 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.